Brief: Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results
08/05/2023 23:34
May 8 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA, INC. REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* THERAVANCE BIOPHARMA INC - Q1 REVENUE $10.4 MILLION
Source text for Eikon: ID:nPn2y0m0Ka
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy